September 8, 2020 06:45 AM EDTUpdated 09:57 AM

Covid-19 roundup: After batting back at vaccine supplier, Inovio lines up a giant in its corner; Oxford spinout SpyBiotech begins PhI/II dosing for VLP-based vaccine

Max Gelman

Senior Editor

John Carroll

Editor & Founder

Inovio announced Tuesday morning that manufacturing giant Thermo Fisher has signed on to make their Covid-19 vaccine INO-4800 in 2021. The biotech — which has yet …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: After batting back at vaccine supplier, Inovio lines up a giant in its corner; Oxford spinout SpyBiotech begins PhI/II dosing for VLP-based vaccine

Max Gelman

Senior Editor

John Carroll

Editor & Founder

Sign up to read this article for free.

Pfizer looking to sell hospital drugs unit — reports

AstraZeneca CEO reaffirms commitment to China following executive's detention

'Expertise is a real thing': FDA commissioner warns of political risk to agency

Merck, AstraZeneca tout Phase 3 win for cancer-turned-rare disease drug

Novartis pays $150M upfront to Schrödinger in new drug deal, ramps up software use

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Covid-19 roundup: Af­ter bat­ting back at vac­cine sup­pli­er, In­ovio lines up a gi­ant in its cor­ner; Ox­ford spin­out Spy­Biotech be­gins PhI/II dos­ing for VLP-based vac­cine

Senior Editor

Editor & Founder

Sign up to read this article for free.

Covid-19 roundup: After batting back at vaccine supplier, Inovio lines up a giant in its corner; Oxford spinout SpyBiotech begins PhI/II dosing for VLP-based vaccine